SLAMF6 regulates basal T cell receptor signaling and influences invariant natural killer T cell lineage diversity
International Immunology · 2025
DOI: 10.1093/intimm/dxaf030 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, 2025. Verfasst von Yukihiro Endo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670Japan. Hauptthemen laut MEDLINE: Natural Killer T-Cells, Signaling Lymphocytic Activation Molecule Family, Signal Transduction, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology, Grant-in-Aid for Scientific Research, Innovative Areas.
Abstract (Originalsprache)
Invariant natural killer T (iNKT) cells differentiate into at least three distinct subsets within the thymus, with each subset’s frequency varying considerably among mouse strains; however, the molecular mechanisms involved remain unclear. We herein report that iNKT cell lineage diversity results from the significant expansion of iNKT2 cells with limited T cell receptor (TCR) diversity in BALB/c mice and the selection of iNKT1 cells with significantly diverse TCRs in B6 mice. Furthermore, signaling lymphocytic-activation molecule family 6 (SLAMF6) expression on immature thymocytes significantly differs among mouse strains, with the low expression of SLAMF6 on BALB/c immature thymocytes resulting in high “basal TCR signaling” in preselected DP thymocytes, associated with iNKT cell expansion. Our data suggest that the expression level of SLAMF6 on immature thymocytes affects basal TCR signaling in preselected DP thymocytes, which may influence thymocyte development in a T-cell subset.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670Japan.
- Institute for Advanced Academic Research, Chiba University, Chiba 263-8522Japan.
- Research Institute of Disaster Medicine, Chiba University, Chiba 260-8670Japan.
- Department of Informatics, National Institute of Genetics, Mishima, Shizuoka 411-0801Japan.
- Department of Genomics and Evolutionary Biology, National Institute of Genetics, Mishima, Shizuoka 411-0801Japan.
- Department of Immunology, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
ORCID-Profile: Koichi Higashi, Atsushi Toyoda
Förderung
- Ministry of Education, Culture, Sports, Science, and Technology
- Grant-in-Aid for Scientific Research
- Innovative Areas
- Challenging Research
- Transformative Research Areas
- Cancer Research and Therapeutic Evolution
- Japan Agency for Medical Research and Development
- National Institutes of Health
Zitieren
APA
Endo, Y., Hasegawa, I., Igi, A., Onodera, A., Mita, S., Higashi, K., Kurokawa, K., Toyoda, A., Kiuchi, M., Shinzawa, M., Wang, Y., Koyama-Nasu, R., Hirahara, K., Motohashi, S., Nakayama, T., & Kimura, M. Y. (2025). SLAMF6 regulates basal T cell receptor signaling and influences invariant natural killer T cell lineage diversity. International Immunology. https://doi.org/10.1093/intimm/dxaf030
Vancouver
Endo Y, Hasegawa I, Igi A, Onodera A, Mita S, Higashi K, et al. SLAMF6 regulates basal T cell receptor signaling and influences invariant natural killer T cell lineage diversity. International Immunology. 2025. doi:10.1093/intimm/dxaf030
BibTeX
@article{Endo2025,
author = {Endo, Yukihiro and Hasegawa, Ichita and Igi, Akemi and Onodera, Atsushi and Mita, Satomi and Higashi, Koichi and Kurokawa, Ken and Toyoda, Atsushi and Kiuchi, Masahiro and Shinzawa, Miho and Wang, Yangsong and Koyama-Nasu, Ryo and Hirahara, Kiyoshi and Motohashi, Shinichiro and Nakayama, Toshinori and Kimura, Motoko Y},
title = {SLAMF6 regulates basal T cell receptor signaling and influences invariant natural killer T cell lineage diversity},
journal = {International Immunology},
year = {2025},
doi = {10.1093/intimm/dxaf030}
}
EUVIMED